Trump’s FDA Goes After Marijuana CBD Oil Distributors

by Pace Lattin
The U.S. Food and Drug Administration is issuing warning letters to four manufacturers of products containing marijuana component cannabidiol (CBD). The companies are, in the FDA’s view, “illegally selling products online that claim to prevent, diagnose, treat or cure cancer without evidence to support these outcomes.Read the full article